Kenvue Inc. $KVUE Shares Purchased by Sumitomo Mitsui Trust Group Inc.

Sumitomo Mitsui Trust Group Inc. boosted its stake in Kenvue Inc. (NYSE:KVUE) by 0.9% in the third quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 4,906,600 shares of the company’s stock after acquiring an additional 44,946 shares during the period. Sumitomo Mitsui Trust Group Inc.’s holdings in Kenvue were worth $79,634,000 as of its most recent SEC filing.

Several other large investors also recently bought and sold shares of the stock. Geneos Wealth Management Inc. lifted its holdings in shares of Kenvue by 384.1% in the 1st quarter. Geneos Wealth Management Inc. now owns 6,632 shares of the company’s stock valued at $159,000 after purchasing an additional 5,262 shares during the last quarter. Parallel Advisors LLC grew its stake in Kenvue by 12.6% during the 2nd quarter. Parallel Advisors LLC now owns 34,038 shares of the company’s stock worth $712,000 after buying an additional 3,801 shares during the last quarter. Czech National Bank increased its position in Kenvue by 6.6% during the second quarter. Czech National Bank now owns 469,294 shares of the company’s stock worth $9,822,000 after buying an additional 28,930 shares during the period. StrongBox Wealth LLC lifted its stake in Kenvue by 8.0% in the second quarter. StrongBox Wealth LLC now owns 93,497 shares of the company’s stock valued at $1,957,000 after buying an additional 6,918 shares during the last quarter. Finally, Financiere des Professionnels Fonds d investissement inc. boosted its holdings in shares of Kenvue by 0.9% in the second quarter. Financiere des Professionnels Fonds d investissement inc. now owns 410,610 shares of the company’s stock valued at $8,594,000 after acquiring an additional 3,519 shares during the period. Institutional investors and hedge funds own 97.64% of the company’s stock.

Wall Street Analyst Weigh In

A number of equities analysts have recently issued reports on KVUE shares. Rothschild Redb upgraded shares of Kenvue from a “hold” rating to a “strong-buy” rating in a research report on Friday, September 26th. Redburn Partners set a $22.00 price target on shares of Kenvue in a research note on Friday, September 26th. Jefferies Financial Group dropped their price objective on shares of Kenvue from $25.00 to $23.00 and set a “buy” rating on the stock in a research note on Monday, October 27th. Edward Jones cut shares of Kenvue from a “strong-buy” rating to a “hold” rating in a report on Monday, November 3rd. Finally, Canaccord Genuity Group reiterated a “hold” rating and set a $15.00 target price (down previously from $26.00) on shares of Kenvue in a research note on Wednesday, October 29th. One investment analyst has rated the stock with a Strong Buy rating, five have given a Buy rating and twelve have assigned a Hold rating to the company. Based on data from MarketBeat.com, the stock has an average rating of “Hold” and a consensus target price of $20.23.

Kenvue Stock Up 0.7%

Shares of Kenvue stock opened at $17.13 on Thursday. Kenvue Inc. has a one year low of $14.02 and a one year high of $25.17. The company has a market cap of $32.81 billion, a P/E ratio of 22.83 and a beta of 0.60. The company has a debt-to-equity ratio of 0.66, a quick ratio of 0.69 and a current ratio of 0.98. The firm has a fifty day moving average of $16.95 and a two-hundred day moving average of $18.32.

Kenvue (NYSE:KVUE) last issued its quarterly earnings results on Monday, November 3rd. The company reported $0.28 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.27 by $0.01. The business had revenue of $3.76 billion for the quarter, compared to analyst estimates of $3.83 billion. Kenvue had a net margin of 9.55% and a return on equity of 20.02%. The business’s revenue was down 3.5% compared to the same quarter last year. During the same period in the previous year, the business posted $0.28 earnings per share. Kenvue has set its FY 2025 guidance at 1.000-1.050 EPS. On average, analysts forecast that Kenvue Inc. will post 1.14 earnings per share for the current year.

Kenvue Announces Dividend

The firm also recently announced a quarterly dividend, which was paid on Wednesday, November 26th. Stockholders of record on Wednesday, November 12th were paid a dividend of $0.2075 per share. This represents a $0.83 dividend on an annualized basis and a dividend yield of 4.8%. The ex-dividend date of this dividend was Wednesday, November 12th. Kenvue’s dividend payout ratio is 110.67%.

Insider Activity

In other Kenvue news, Director Jeffrey C. Smith purchased 3,200,000 shares of Kenvue stock in a transaction dated Friday, December 12th. The stock was acquired at an average cost of $17.37 per share, with a total value of $55,584,000.00. Following the acquisition, the director directly owned 27,307,632 shares of the company’s stock, valued at $474,333,567.84. This represents a 13.27% increase in their ownership of the stock. The purchase was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Company insiders own 1.68% of the company’s stock.

Kenvue Company Profile

Kenvue is a consumer health company that was established as a standalone, publicly traded business after separating from Johnson & Johnson. Listed on the New York Stock Exchange under the symbol KVUE, Kenvue focuses on the development, manufacture, marketing and distribution of consumer health and personal care products across a range of categories including skin and beauty care, baby care, oral care, wound care and over‑the‑counter medicines.

The company owns and markets a portfolio of widely recognized consumer brands, including names familiar to global shoppers across retail and pharmacy channels.